Abidi, SH, Sherwani, SK, Siddiqui, TR, Bashir, A, Kazmi, SU. (2013). Drug resistance profile and biofilm-forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan. BMC Ophthalmol., 13(1):57.
Brandenburg, KS, Calderon, DF, Kierski, PR, Brown, AL, Shah, NM, Abbott, NL, Schurr, MJ, Murphy, CJ, McAnulty, JF, Czuprynski, CJ. (2015). Inhibition of Pseudomonas aeruginosa biofilm formation on wound dressings. Wound Repair. Regen., 23(6):842-854.
Buhl, M, Peter, S, Willmann, M. (2015). Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review. Expert Rev. Anti Infect Ther., 13(9):1159-1170.
Fratesi, SE, Lynch, FL, Kirkland, BL, Brown, LR. (2004). Effects of SEM preparation techniques on the appearance of bacteria and biofilms in the Carter Sandstone. J. Sediment. Res., 74(6):858-867.
Hassan, A, Usman, J, Kaleem, F, Omair, M, Khalid, A, Iqbal, M. (2011). Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz. J. Infect Dis., 15(4):305-311.
Khan, W, Bernier, SP, Kuchma, SL, Hammond, JH, Hasan, F, O’Toole, GA. (2010). Aminoglycoside resistance of Pseudomonas aeruginosa biofilms modulated by extracellular polysaccharide. Int. Microbiol., 13(4):207.
Kolter, R. (2010). Biofilms in lab and nature: a molecular geneticist’s voyage to microbial ecology. Int. Microbiol., 13(7):1-7
Laverty, G, Gorman, S, Gilmore, B. (2014). Biomolecular mechanisms of Pseudomonas aeruginosa and Escherichia coli biofilm formation. Pathogens., 3(3):596-632.
Naves, P, Del Prado, G, Huelves, L, Gracia M, Ruiz, V, Blanco, J, Rodríguez-Cerrato, V, Ponte, MC, Soriano, F. (2008). Measurement of biofilm formation by clinical isolates of Escherichia coli is method‐dependent. J. Appl. Microbiol., 105(2):585-590.
Overhage, J, Schemionek, M, Webb, JS, Rehm, BH. (2005). Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm formation. Appl. Environ. Microbiol., 71(8):4407-4413.
Peleg, AY, Hooper, DC. (2010). Hospital-acquired infections due to gram-negative bacteria. N. Engl. J. Med., 362(19):1804-1813.
Perez, LRR, Costa, MCN, Freitas, ALP, Barth, AL. (2011). Evaluation of biofilm production by Pseudomonas aeruginosa isolates recovered from cystic fibrosis and non-cystic fibrosis patients. Braz. J. Microbiol., 42(2):476-479.
Porras-Gómez, M, Vega-Baudrit, J, Núñez-Corrales, S. (2012). Overview of multidrug-resistant Pseudomonas aeruginosa and novel therapeutic approaches. J. Biomater. Nanobiotechnol., 3(04):519.
Seshadri, S, Chhatbar, C. (2009). Multidrug resistance in Pseudomonas aeruginosa: Insights into the molecular mechanisms. Afr. J. Microbiol. Res., 3(5):195-199.
Shahandashti, EF, Molana, Z, Asgharpour, F, Mojtahedi, A, Rajabnia, R. (2012). Molecular detection of Integron genes and pattern of antibiotic resistance in Pseudomonas aeruginosa strains isolated from intensive care unit, Shahid Beheshti Hospital, North of Iran. Int. J. Mol. Cell. Med., 1(4):209.
Verma, U, Kulshreshtha, S, Khatri, P. (2018). MDR Pseudomonas aeruginosa in nosocomial infection: burden in ICU and burn units of a tertiary care hospital. Int. J. Curr. Microbiol. Appl. Sci., 7:1267-1274.
Wei, Q, Ma, L. (2013). Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int. J. Mol. Sci., 14(10):20983-21005.
Zaidenstein, R, Miller, A, Tal-Jasper, R, Ofer-Friedman, H, Sklarz, M, Katz, DE, Lazarovitch, T, Lephart, PR, Mengesha, B, Tzuman, O, Dadon, M, Daniel, C, Moran-Gilad, J, Marchaim, D. (2018). Therapeutic Management of Pseudomonas aeruginosa Bloodstream Infection Non-Susceptible to Carbapenems but Susceptible to “Old” Cephalosporins and/or to Penicillins. Microorganisms., 6(1):9.